APA (7th ed.) Citation

Sun, Y., Veccia, D., Liu, B. D. X., Tse, W., Fass, R., & Song, G. (2025). Diagnostic Evaluation of an Increased Risk of Developing Small Intestinal Bacterial Overgrowth Associated with Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Dual GLP-1/GIP Receptor Agonists: A Global Retrospective Multicenter Cohort Analysis. Diagnostics (2075-4418), 15(17), 2264. https://doi.org/10.3390/diagnostics15172264

Chicago Style (17th ed.) Citation

Sun, Yan, Donovan Veccia, Benjamin Douglas Xun Liu, William Tse, Ronnie Fass, and Gengqing Song. "Diagnostic Evaluation of an Increased Risk of Developing Small Intestinal Bacterial Overgrowth Associated with Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Dual GLP-1/GIP Receptor Agonists: A Global Retrospective Multicenter Cohort Analysis." Diagnostics (2075-4418) 15, no. 17 (2025): 2264. https://doi.org/10.3390/diagnostics15172264.

MLA (9th ed.) Citation

Sun, Yan, et al. "Diagnostic Evaluation of an Increased Risk of Developing Small Intestinal Bacterial Overgrowth Associated with Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Dual GLP-1/GIP Receptor Agonists: A Global Retrospective Multicenter Cohort Analysis." Diagnostics (2075-4418), vol. 15, no. 17, 2025, p. 2264, https://doi.org/10.3390/diagnostics15172264.